About The Conference
The Allied Academies warmly welcome you to participate in the “31st International Conference on Diabetes and Endocrinology” on February 06-08, 2023 in Paris, France.
The Diabetes Congress 2023 will be remembered for bringing together international specialists and researchers to debate current conditions and case studies, future developments, and advancements in the field of Diabetes and Endocrinology, and Metabolism. All of the planned sessions will include sub-sessions to help make the event more intelligible, and all of the important topics will be presented in some detail. Because the Diabetes Congress 2023 will be held over three days, the sessions will be concentrated on diabetes, endocrinology, and metabolism.
Diabetes Congress 2023 is a Hybrid event!! Our objective is to establish a diabetic networking community of people from many countries who are unable to travel because of the current pandemic scenario, financial constraints, or other personal reasons. As a result, the Diabetes Congress 2023 will be hosted by both a physical and virtual platform.
Significance and Scope:
The primary goal of the Diabetes Congress 2023 is to disseminate scientific and medical research and ideas regarding diabetes-related problems, including endocrine illnesses, around the world and to get a better understanding of them. We encourage research such as the Diabetes Congress 2023 to globalize the demand for knowledge about Diabetes, Endocrine, and Metabolic disorders through worldwide choices and conversations that will result in outstanding solutions to existing Diabetes and Endocrinology health concerns. Diabetes arises in a number of forms, which increases the need for therapy. As a result, the Diabetes Congress 2023 conference will provide an excellent opportunity to discuss all of the critical strategies and ongoing research to reduce diabetic patients worldwide.
Diabetes and Endocrinology are large fields, and researchers are focusing on new ideas and enhancing existing ways to better diabetes therapies. This is an excellent chance to build a global alliance of brilliant individuals from many countries who are experts in diabetes and Endocrinology laws, as well as to discuss your research and ideas in breakout sessions with bright minds.
Experts from many professions, including doctors, dieticians, nurses, physicians, pharmacists, academic researchers, and other healthcare professionals, will attend the Diabetes Congress 2023. They discuss diabetic and endocrine problems, including complications, side effects, and precautions. Modern technologies that help decrease diabetes and endocrine problems in humans are also highlighted.
ü Keynote speakers and session speakers
ü Young Research Forum (YRF)
ü The platform and arrangements for organizing symposiums and workshops
ü Research results and suggestions
ü Exhibition of new goods and gadgets relevant to the Diabetes Congress 2023
Diabetes, Endocrinology, and Metabolism
Faculty | Diabetologist | Gynaecologists | Podiatrists | Medicare Associations | Healthcare Associations | Diabetes & Metabolism
Researchers | Business Entrepreneur | Physicians | Ophthalmologists | Medical Colleges | Academic Researchers | Neurologists | Endocrinology Societies &
Associations | Endocrinologists | Diabetes Societies &
Associations | Nutritionists | Manufacturing Medical Device
Companies | Oncologist | Training Institutes | Pharmaceutical Companies.
The 31st International Conference on Diabetes and Endocrinology will be held in Paris, France on February 06-08, 2023. Diabetes Congress 2023 aims to bring together all of the world's best diabetes and endocrinology scientists, researchers, and doctors, as well as medical professionals, pharmaceutical businesses, and healthcare providers. The conference's subject is "Advanced medical research and applications on diabetes condition and endocrine functions", meaning that it will be a place for researching modernity in the field of diabetes. This conference will include the most recent advances in diabetes and endocrinology, as well as therapeutic insights. Attendees from universities and institutions will have a wonderful opportunity to network with scientists, researchers, and promoters at this conference.
Join us in Paris, France for the Diabetes and Endocrinology Conference!
Session 1: Diabetes Mellitus
Diabetes is a prevalent chronic condition that places high demands on the individual's immune system. Diabetes is classified into three types: type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 1 Diabetes Mellitus is caused by the auto-immune loss of the pancreas' insulin-producing beta cells. Auto-antibody testing and the C-peptide test can distinguish type 1 diabetes from type 2 diabetes. Diabetes type 1 accounts for 10% of all diabetic patients. Diabetes Mellitus Type 2 is a metabolic condition characterised by insulin resistance and a lack of insulin.
· 1. Type 1 Diabetes Mellitus
· 2. Type 2 Diabetes Mellitus
Session 2: Diabetes types and complications
Diabetes complications range from life-threatening disorders such as acute hyperglycaemia to debilitating complications that damage the organ systems of the body. Estimating the prevalence of diabetic complications is challenging due to the lack of worldwide agreements on regular diabetes diagnosis. Diabetes complications such as retinopathy, nephropathy, and cardiovascular systems will be discussed at this session of the Diabetes Congress 2023.
· 1. Dermatology
· 2. Pre-diabetes
· 3. Dental Health
· 4. Nephropathy
· 5. Retinopathy
· 6. Neuropathy
· 7. Cardiovascular problems
Session 3: Gestational diabetes
GDM (Gestational Diabetes Mellitus) is a developing global health issue that can damage both the mother and the child in the short and long term. Regardless matter how critical it is, many nations continue to lack the epidemiological data necessary to respond to diabetes-related disorders. Diabetes and obesity are prevalent in many countries due to a lack of knowledge regarding GDM. Diabetes affects one out of every three women of reproductive age and one out of every seven children, according to data. This session will cover a variety of topics concerning Gestational Diabetes.
· 1. Overview: Diabetes and Women's Health
· 2. Diabetes symptoms in women
· 3. Diabetes-Free Pregnancy: Postpartum Recommendations
Session 4: Genetic diabetes
Many individuals throughout the world are still unaware of what genetic diabetes is. This allows people to enter pre-diabetic phases without ever realising it, which causes a plethora of problems. Because of hereditary factors that are activated, certain people are predisposed to Diabetic diseases. We are predisposed to diabetes from birth, and something in our environment triggers it. This, however, is not always the case. Other occurrences may cause the Diabetic conditions to be thresholded. This genetic Diabetes presentation will go through the precautions and treatments that must be taken to avoid inherited Diabetes.
· 1. Predictions and safeguards
· 2. Factors that cause genetic diabetes
· 3. Genes and Family Tree
· 4. Genetic Diabetes Complications
Diabetes mellitus, sometimes known as diabetes, is a metabolic disorder characterised by high blood sugar levels. Insulin is a hormone that transports sugar from circulation into your cells, where it is stored or utilised for energy. If you have diabetes, your body either does not produce enough insulin or cannot efficiently utilise the insulin that it does produce. Diabetes symptoms are exacerbated by an increase in blood sugar. The vast majority of persons who arrive with typical diabetes symptoms receive a clear diagnosis. Diabetes management aims to enhance the quality of life and productivity of diabetics.
· 1. Diabetes education includes both type 1 and type 2 diabetes.
· 2. Diabetes during pregnancy
· 3. Diabetes risk factors and symptoms
· 4. Blood sugar levels at random and during fasting
· 5. Diet and physical exercise in diabetes
· 6. Diabetes medication management
AI is described as "a branch of computer science that tries to develop systems or methods for analysing information and managing complexity in a wide range of applications". AI is a practical and appealing choice for effective data management and the creation of diabetes care tools and devices. Artificial intelligence (AI) is a fast-expanding discipline, and its applications to diabetes, a worldwide pandemic, have the potential to alter the way diabetes is diagnosed and controlled. Machine learning methods have been used to develop algorithms to enable predictive models for the risk of diabetes and its complications.
· 1. Artificial Intelligence in Diabetes Education
· 2. AI and big data in diabetes control
· 3. AI Diagnosis of Diabetic Retinopathy
· 4. Monitoring for Complications
Session 7: Physiology and Pathophysiology of Diabetes
Physiology is the study of the processes and mechanisms that occur within an organism. Disease physiology is usually complicated, requiring interactions across several organs and tissue types. The pathophysiology of diabetes is connected to insulin levels in the body as well as the body's capacity to use insulin. Type 1 diabetes has no insulin, but type 2 diabetes has peripheral tissues that resist insulin's actions. Diabetes has a complicated aetiology involving several hormones (i.e., insulin, glucagon, and growth). The pathological processes of this illness are difficult to pin down and vary widely between patients due to the interplay of these hormones with the liver and their role in renal function.
· 1. Diabetes management
· 2. Diabetes and Chronic Oxidative Stress
Session 8: Insulin Devices and Diabetes Medication
The inability of the body to manufacture insulin is the primary cause of diabetes. Insulin is divided into different groups based on how long it takes to take effect. Insulin is injected into diabetics who cannot control their condition with oral medications. The emphasis is mostly on diabetes medicine and cutting-edge technology.
· 1. Rapid-acting insulin
· 2. Short-acting insulin
· 3. Intermediate-acting insulin
· 4. Long-acting insulin
Session 09: Diabetes and Cardiology
Diabetes is a cardiovascular and metabolic illness marked by inflammation. It increases almost every cardiovascular risk factor, and the vast majority of diabetics die from heart disease. Recent clinical research discoveries, together with patient education, offer new avenues for improving cardiovascular outcomes in diabetes patients. Diabetes and cardiovascular disease (CVD) have a complex aetiology. Understanding these complicated disease pathways can help clinicians recognise and treat CVD in diabetes patients, as well as help patients avoid potentially deadly effects.
Diabetic cardiomyopathy refers to cardiovascular disorders that occur in diabetic people and are not caused by another recognised CVD, such as hypertension or coronary artery disease. Diabetes patients are predisposed to heart failure even early in the course of their disease due to morphological and functional abnormalities in diabetic cardiomyopathy.
· 1. Diabetes and Cardiovascular Interaction
· 2. Diabetes and Cardiovascular Disease
· 3. Diabetes-Related Cardiomyopathy
Session 10: Diabetes and Obesity
Obesity is often caused by an underlying condition characterised by excessive body fat build-up. It has a major negative impact on health, especially by raising the risk of other chronic illnesses such as heart disease and diabetes. Obesity is defined as a BMI of more than 30 kg/m2. Obesity is one of the most prevalent disorders in developed nations, and its prevalence is rising.
Obesity increases the risk of developing type 2 diabetes, also known as insulin-resistant diabetes or adult-onset diabetes. This is when your blood glucose level remains elevated over a lengthy period of time. According to a study, obese people are up to 80 times more likely than non-obese people to acquire type 2 diabetes.
· 1. Metabolic Syndrome
· 2. Weight Loss Surgery
· 3. Weight control
· 4. Obesity, Nutrition, and Exercise
Diabetes technology refers to the gear, equipment, and software that diabetics utilise to help them manage their blood glucose levels, minimise diabetes complications, reduce the burden of living with diabetes, and enhance their quality of life. Diabetes technology has traditionally been divided into two categories: insulin delivery through a syringe, pen, or pump, and blood glucose monitoring via metre or continuous glucose monitor. Diabetes technology has lately advanced to include hybrid devices that monitor glucose and dispense insulin, some of which are automated, as well as software that functions as a medical device and aids in diabetes self-management. Diabetes technology, when utilised successfully, may improve people's lives and health; yet, the complexity and rapid growth of the diabetes technology environment can be a barrier to patient and provider adoption.
· 1. Clinical Insights
· 2. Latest Research and Developments Specific to Diabetes Technology
Session 12: Nanotechnology in Diabetes Treatment
In diabetes research, nanotechnology has contributed to the development of novel glucose testing and insulin delivery methods, which have the potential to greatly enhance diabetics' quality of life. This topic includes nanomaterials, nanostructures, nanoparticle design, and their applications in humans. It also gives more exact information for the diagnosis of diabetes mellitus. To help in the early identification of type 1 diabetes, nanoparticles are being created as contrast agents, and several formulations have been investigated in human clinical studies. Nanotechnology is being used to help engineers design more effective vaccinations with the aim of creating a cure for type 1 diabetes.
· 1. Nanovaccines
· 2. Nanosensors
· 3. Nanomedicine
Session 13: Endocrinology
Even though glucose consumption fluctuates significantly, living beings rely on hormones produced by the endocrine glands to maintain a constant blood glucose level throughout their lives. Hormone production in the blood activates the pathways by restoring normal blood glucose levels. Because the endocrine system is such an essential component of our bodies, several research is being undertaken on it. Learning more about the endocrine system can help us come up with new ways to prevent illnesses like diabetes.
· 1. Hormones and endocrine glands
· 2. Endocrinology Types
· 3. Endocrinology and diabetic complications
Session 14: Paediatric endocrinology
Paediatric endocrinology is the study of endocrinology in children. Paediatric endocrinologists treat children with type 1 and type 2 growth difficulties, pubertal abnormalities, obesity, sex development differences, bone and mineral changes, hypoglycaemia, and various diseases of the adrenal, parathyroid, thyroid, and pituitary glands.
· 1. Immunological influences on behaviour
· 2. Thyroid gland enlargement
· 3. Early-experience endocrine activation
· 4. Hormone of growth
Session 15: Metabolic syndrome
A cluster of conditions that raise the chance of developing heart disease, stroke, or diabetes.
Excessive blood pressure, high blood sugar, increased body fat around the waist, and abnormal cholesterol levels are all symptoms of metabolic syndrome. The condition raises a person's chance of having a heart attack or a stroke.
Most metabolic syndrome-related illnesses have no symptoms other than a big waist circumference. Weight loss, exercise, a nutritious diet, and quitting smoking can all help. Medication may be prescribed as well.
· 1. Coronary Heart Disease
· 2. Diabetes
· 3. Stroke
· 4. Nonalcoholic Fatty Liver Disease (NAFLD)
Session 16: Endocrine Bone Disease
Diabetes, particularly type 1 diabetes, is associated with poor bone quality and an increased risk of fractures. Those with long-standing illness, poor blood sugar management, and who use insulin are at the greatest risk of fracture.
Diabetes mellitus may have a negative impact on bone metabolism and bone quality. Diabetes promotes osteoclast function while decreasing osteoblast function, resulting in accelerated bone loss, osteopenia, and osteoporosis.
· 1. Swelling and redness in the infected area
· 3. Osteoporosis in Women
· 4. Socio and economic impact of Osteopenia
Session 17: Neuroendocrinology
Neuroendocrinology is the study of the relationship between the neurological and endocrine systems and how they communicate. To manage the physiological forms of the human body, the neurological and endocrine systems usually work together in a process known as neuroendocrine integration. Neuroendocrinology arose from the recognition that the brain, particularly the hypothalamus, regulates pituitary hormone release and has now expanded to investigate numerous interconnections of the endocrine and nervous systems. The neuroendocrine framework is the component by which the hypothalamus maintains homeostasis by governing generation, digestion, eating and drinking habits, vitality utilisation, osmolality, and blood weight.
· 1. Neuroendocrine and types of Cancer
· 2. Behavioural Neuroendocrinology
· 3. Idiopathic Short Stature
· 4. Neuroendocrine Pancreatic cancer
· 5. Hormone Therapy for Hyposecretion
Session 18: Endocrine Oncology
Endocrine oncology is the speciality of medicine that deals with tumours caused by thyroid hormones, often known as endocrine neoplasia. There are two types of endocrine neoplasia; both are genetic abnormalities that can be passed down from generation to generation. The first kind is called as warmers disorder, while the second type is known as pheochromocytoma or straightforward condition, both of which resulted in medullary thyroid cancer.
· 1. Adrenal gland tumors
· 2. Multiple endocrine neoplasias 1 (MEN1)
· 3. Multiple endocrine neoplasias 2 (MEN 2)
· 4. Parathyroid gland tumors
· 5. Pituitary gland tumors
· 6. Thyroid cancer
· 7. Pancreatic cancer
Session 19: Adrenal and Thyroid Disorders
Adrenal organs are little organs that sit on top of each kidney. They produce hormones that you can't live without, like sex hormones and cortisol. Cortisol influences how you react to stress and has a variety of other important functions. There is too much cortisol in Cushing's disease, whereas it is too little in Addison's disease. Thyroid organ influences practically all metabolic types in your body. Thyroid clogs can range from a minor, harmless goitre (expanded organ) that does not require treatment to life-threatening malignancy. Hyperthyroidism is characterised by an excess of thyroid hormone. Hypothyroidism is caused by insufficient hormone production.
· 1. Adrenal disorders
· 2. Thyroid Disorders and Parathyroid Disorders
· 3. Disorders of Calcium Metabolism and Vitamin-D Deficiencies
· 4. Adrenal Tumors and Thyroid Tumors
Session 20: Endocrinology and Nephrology
Systemic ailments such as diabetes mellitus and immune system sickness can have an impact on the kidneys, and clutters can set the stage for severe or ongoing kidney infection. Chronic kidney infection has been documented to affect 10% to 15% of the general population worldwide, and treating people with kidney disease is a complicated task. Endocrine-disrupting substances, including heavy metals, may contribute to the improvement and progression of chronic renal disease. There is a well-known substantial overlap between nephrology and endocrinology, owing to shared pathophysiologic interactions. Despite the fact that the kidney plays an important role in body homeostasis, i.e., liquid and electrolyte adjustment, as well as administrative control of blood pressure, it is important to recognise that it isn't essentially an excretory organ, because it applies numerous endocrine capacities, in fact, playing a significant role including hormones included in the renin-angiotensin-aldosterone framework, erythropoietin.
· 1. Diabetes Mellitus and Autoimmune Disease
· 2. Autoimmune Disease
· 3. Chronic Kidney Disease
· 4. Endocrine Disrupting Chemicals
· 5. Diabetic Nephropathy
Session 21: Cellular and Molecular Endocrinology
Cellular and molecular endocrinology examines the cell science and atomic structure of hormones and their endocrine glands. Cellular and molecular endocrinology research focuses on bone metabolism, thyroid issues, calcium's role in atherogenesis, and muscle metabolism. This talk will go through DNA technology and its applications in a variety of sectors. The main purpose of this session is to share the most recent techniques and discoveries in cellular and molecular endocrinology and apply them to endocrine issues.
· 1. Recombinant DNA technology
· 2. Pathophysiology of diabetes
· 3. Autoimmune Disease: T1D
· 4. Insulin Resistance: T2D
Session 22: Nutritional Diet, Exercise and Metabolism
Nutrition and blood glucose regulation in our bodies are inextricably linked, and the role of vitamins and other nutrition in diabetes regulation is unavoidable. Diabetes is exacerbated by malnutrition. According to statistics, only 15-38% of individuals are malnourished. Dietary variables and regular exercise are critical for managing and preventing diabetes. Diabetes also has an impact on the human body's metabolism, which should typically be functioning properly. The patient's entire body is affected by irregular metabolism. Problems with insulin production and receptors are caused in part by faulty metabolism, which will lead to Diabetes being a chronic disease. This lesson will go through the dietary and metabolic aspects of diabetes.
· 1. Early childhood nutrition
· 2. Dietary modification for Diabetes
· 3. Influence of traditional therapy on diabetes
· 4. Metabolic disorders and drug metabolism
Session 23: Advancements in Diabetes and Endocrinology
Different Diabetes and Endocrinology Center was established to improve the quality of life for people with diabetes and other endocrinology disorders. Complications and pains for diabetic patients add to excessive anticipation and treatment. Counting knobs inside the endocrine framework for patients with various endocrinology clutters. Unused breakthroughs have been developed to keep everyone safe from Metabolic Disorders.
· 1. Informatics in the Service of Medicine
· 2. Bariatric
· 3. Glucometer
· 4. Telemedicine Software and other Technologies
· 5. Treating Obesity and Preventing Related Diabetes
Session 24: Global Diabetes Market
The diabetes market has evolved dramatically over the last 20 years as a consequence of increasing innovation and modernization of therapeutic treatments. Because the aliment is so widespread, and patient numbers are expected to climb in the near future, medication developers have discovered it to be a profitable industry. As a result, the worldwide market size, as defined by pharmaceutical sales, has increased sixfold since 2000, according to Global Data, a renowned data and analytics group. From $19.7 billion in 2020 to $27.0 billion in 2025, the global market for diabetes monitoring devices is predicted to rise at a compound annual growth rate (CAGR) of 6.5 percent.
· 1. Diabetes Monitoring Devices Global Market
· 2. Global Market Trend Analysis
· 3. Trends in Regulatory and Economic Policy affecting the market
Session 25: Stem Cell Treatment in Diabetes
This study made use of autologous hematopoietic stem cells. They are the same as stem cells derived from cord blood. Understanding how the study's findings might help people who save cord blood at birth, as type 1 diabetes (also known as juvenile diabetes) is an autoimmune disease that hits children at a young age. Cord blood is a healthy blood type.
· 1. Diabetes Treatment
· 2. Stem Cell Therapy
· 3. Type 1 Diabetes Beta Cell
· 4. Stem Cell and Diabetes
Session 26: Herbal and Natural Therapies
Many common herbs and spices are thought to have blood sugar-lowering properties, making them beneficial to those with type 2 diabetes or at high risk of getting it. A number of clinical studies in recent years have discovered possible links between herbal medications and improved blood glucose management, leading to an increase in people with diabetes using these more "natural" substances to help manage their disease.
Session 27: Case Reports and Others
Lipid disorders are a
set of medical illnesses characterised by high amounts of fatty compounds in
the blood. Triglycerides
and cholesterol are examples of fatty compounds. An overabundance of bad
cholesterol raises your chances of developing heart disease and stroke. A
paraganglioma is an uncommon neuroendocrine tumour that can develop anywhere in
the body (including the head, neck, thorax and abdomen). Approximately 97% are
benign and may be removed surgically; the remaining 3% are malignant neoplasms
that can cause distant metastases. The name "paraganglioma"
is presently the most extensively used to describe these lesions, which have
previously been called glomus tumour, chemodectoma, perithelioma,
fibroangioma, and congenital nevi. Metabolic bone strength issues are often
caused by deficiencies in minerals (such as calcium or phosphorus), vitamin D,
bone mass, or bone structure. Osteoporosis is the most prevalent metabolic bone
The France Diabetes Devices Market is estimated to grow at a CAGR of more than 7% between 2022 and 2027.
Diabetes is the most significant frequency of any chronic ailment covered entirely by France's statutory health insurance (SHI), and the number of people insured has more than quadrupled in the last decade. France is a prominent country in the European Union. Diabetes is becoming more common among individuals of all ages in France, which may be ascribed to an increasingly obese population and bad diets and sedentary lifestyles. Furthermore, it is predicted that 0.26 million people in the region have Type 1 diabetes. Thus, rising diabetes and obesity incidence, increased awareness of diabetic care, healthcare spending, and technological improvements are a few drivers driving the market for diabetes care devices in France.
In France, insurance programmes help to alleviate the burden on the diabetic community. However, there are separate regulations for Type 1 and Type 2 diabetics. For example, the insurance covers up to 200-400 test strips per year for the Type 2 population, but it covers around 3,000 test strips per year for the Type 1 population.
Over the projection period 2022-2027, the population of people with type 1 diabetes in France increased at a rate of more than 3%. France is one of 59 countries in the IDF EUR zone. Furthermore, diabetes will affect 61 million people in Europe and 537 million people globally in 2021, rising to 69 million by 2045.
According to an EU Commission poll, the number of people with chronic diabetes is highest in France, with one in every ten people suffering from the disease. Diabetes is common in France, despite the fact that the guidelines' aim of 80% compliance with recommended healthcare visits is not always fulfilled. To encourage proactive therapy adjustment and diminish therapeutic inertia, innovative strategies focusing on patient and physician education and information are required to reduce the burden of diabetic complications and hospitalizations.
Major Associations of
Endocrinology around the globe:
· Brazilian Society of Surgical Endocrinology
Major Associations of Diabetes:
- American Diabetes Association
- Apollo Sugar Limited
- Barton Center for Diabetes Education
- Central European Diabetes Association
- Diabetes Australia
- Diabetes Canada
- Diabetes UK
- European Association for the Study of Diabetes
- Joslin Diabetes Center
- International Diabetes Federation
- Pacific Northwest Diabetes Research Institute
- Steno Diabetes Center
- Team Novo Nordisk